465 filings
Page 2 of 24
8-K
0mz7y185m2ef35ys y0
13 Nov 23
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
12:00am
8-K
lpcr4e7 iigt
23 Oct 23
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
4:30pm
3
ezi40
20 Oct 23
Acasti Pharma / George Kottayil ownership change
12:23pm
3
zqb1 pmim
20 Oct 23
Acasti Pharma / EDWARD NEUGEBOREN ownership change
12:22pm
3
1mg2c41q 92tqq00bo
20 Oct 23
Acasti Pharma / A BRIAN DAVIS ownership change
12:21pm
EFFECT
nk1n3h8jgepwda7lbjg
17 Oct 23
Notice of effectiveness
12:15am
424B3
a10of9 f4ya8c3v66
16 Oct 23
Prospectus supplement
4:31pm
CORRESP
ati3 3uaew8zr
12 Oct 23
Correspondence with SEC
12:00am
UPLOAD
yaqa4omni
12 Oct 23
Letter from SEC
12:00am
8-K
b4ksep2
11 Oct 23
Submission of Matters to a Vote of Security Holders
4:30pm
D
v3b f32oi9xt
10 Oct 23
$15.12 mm in equity / options / securities to be acquired, sold $7.50 mm, 4 investors
7:40am
4
54unv is1optvc61e
27 Sep 23
Acasti Pharma / Vimal Kavuru ownership change
7:46pm
8-K
7u4m1 51p2ks
26 Sep 23
Acasti Announces $7.5 Million Private Placement Equity Financing
8:10am
4
c1ogo
5 Sep 23
Acasti Pharma / Donald Olds ownership change
3:54pm
S-8
8kxa4p
25 Aug 23
Registration of securities for employees
5:01pm
DEFA14A
qvqhrdjatnyzfntw
25 Aug 23
Additional proxy soliciting materials
4:21pm
8-K
o8mj4yn344fg6hn5mb
11 Aug 23
Acasti Announces First Quarter 2024 Financial Results and Business Highlights
7:31am